Xalles Holdings Inc (XALL)

[BIOCHEMUP]

Xalles has received a Letter of Interest from Continuation Capital, an institutional investor, to potentially fund all or part of this Tier I offering and part of a subsequently planned Tier II offering.

$XALL Xalles has received a Letter of Interest from Continuation Capital, an institutional investor, to potentially fund all or part of this Tier I offering and part of a subsequently planned Tier II offering. https://t.co/92WMT4GI41. #XALL, #fintech

— Xalles (@xalles1) March 26, 2020

Audited annual financials by a PCAOB auditor and OTCQB uplisting in the not too distant future?